|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000083093 |
Summary for PALB2 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000083093 | Gene symbol | PALB2 |
| Gene name | partner and localizer of BRCA2 | |
| HGNC | 26144 | |
| Entrez ID | 79728 | |
| Gene type | protein_coding | |
| Synonyms | PALB2|FLJ21816|FANCN | |
| UniProtAcc | Q86YC2 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for PALB2 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| PALB2 | 9.88e+02 | 1.10e+00 | 2.17e-01 | 5.05e+00 | 4.43e-07 | 3.77e-06 | BLCA |
| Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Top |
Sex-biased somatic mutation for PALB2 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for PALB2 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Top |
Exon skipping events with PSI in TCGA for PALB2 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for PALB2 |
| ∗Please access CAeditome for RNA editing annotation. |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for PALB2 |
| TFs related to PALB2. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| ACC | ZNF182 | PALB2 | 4.05e+00 | 9.82e-01 | 3.19e+00 | 7.31e-03 | Male-biased |
| ACC | ZNF487 | PALB2 | 4.11e+00 | 9.82e-01 | 3.25e+00 | 7.78e-03 | Male-biased |
| BLCA | PRDM6 | PALB2 | 4.23e+00 | 9.85e-01 | 3.18e+00 | 4.13e-03 | Male-biased |
| BLCA | ZNF182 | PALB2 | 4.36e+00 | 9.87e-01 | 3.32e+00 | 4.35e-03 | Male-biased |
| BLCA | ZNF22 | PALB2 | 4.36e+00 | 9.87e-01 | 3.32e+00 | 4.29e-03 | Male-biased |
| BLCA | ZNF235 | PALB2 | 4.54e+00 | 9.90e-01 | 3.47e+00 | 4.01e-03 | Male-biased |
| BLCA | ZNF384 | PALB2 | 4.09e+00 | 9.80e-01 | 3.15e+00 | 5.97e-03 | Male-biased |
| BLCA | ZNF487 | PALB2 | 4.35e+00 | 9.87e-01 | 3.29e+00 | 4.01e-03 | Male-biased |
| BLCA | ZNF613 | PALB2 | 4.28e+00 | 9.84e-01 | 3.35e+00 | 6.10e-03 | Male-biased |
| BLCA | ZNF79 | PALB2 | 4.23e+00 | 9.81e-01 | 3.37e+00 | 7.84e-03 | Male-biased |
| PALB2 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for PALB2 |
| RBPs related to ES in PALB2. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| STAD | QKI | exon_skip_143169 | 1.29e+01 | 5.44e-03 | 1.33e+01 | 9.94e-01 | Female-biased |
| ACC | MSI1 | exon_skip_143172 | 1.44e+01 | 9.95e-01 | 1.39e+01 | 4.71e-03 | Male-biased |
| ACC | QKI | exon_skip_143169 | 1.35e+01 | 9.94e-01 | 1.30e+01 | 5.71e-03 | Male-biased |
| THYM | QKI | exon_skip_143169 | 1.35e+01 | 1.01e-03 | 1.41e+01 | 9.99e-01 | Female-biased |
| DLBC | MSI1 | exon_skip_143172 | 1.54e+01 | 9.99e-01 | 1.48e+01 | 1.13e-03 | Male-biased |
| DLBC | QKI | exon_skip_143172 | 1.30e+01 | 9.91e-01 | 1.26e+01 | 9.07e-03 | Male-biased |
| KIRP | MSI1 | exon_skip_143172 | 1.48e+01 | 9.99e-01 | 1.43e+01 | 8.07e-04 | Male-biased |
| KIRP | QKI | exon_skip_143172 | 1.29e+01 | 9.99e-01 | 1.23e+01 | 4.32e-04 | Male-biased |
| BRCA | MSI1 | exon_skip_143172 | 1.43e+01 | 9.87e-01 | 1.37e+01 | 1.25e-02 | Male-biased |
| READ | KHDRBS1 | exon_skip_143172 | 6.94e+00 | 4.48e-03 | 7.35e+00 | 9.84e-01 | Female-biased |
| READ | MSI1 | exon_skip_143172 | 1.42e+01 | 1.11e-03 | 1.47e+01 | 9.99e-01 | Female-biased |
| READ | QKI | exon_skip_143172 | 1.15e+01 | 1.64e-03 | 1.20e+01 | 9.98e-01 | Female-biased |
| THCA | PABPC3 | exon_skip_143169 | 8.47e+00 | 9.87e-01 | 8.15e+00 | 6.86e-03 | Male-biased |
| THCA | QKI | exon_skip_143169 | 1.34e+01 | 9.99e-01 | 1.29e+01 | 6.98e-04 | Male-biased |
| MESO | QKI | exon_skip_143169 | 1.32e+01 | 5.16e-04 | 1.38e+01 | 9.99e-01 | Female-biased |
| LGG | MSI1 | exon_skip_143172 | 1.36e+01 | 3.18e-03 | 1.41e+01 | 9.97e-01 | Female-biased |
| LGG | QKI | exon_skip_143172 | 1.17e+01 | 4.95e-03 | 1.21e+01 | 9.95e-01 | Female-biased |
| GBM | QKI | exon_skip_143169 | 1.30e+01 | 5.75e-04 | 1.36e+01 | 9.99e-01 | Female-biased |
| KICH | QKI | exon_skip_143169 | 1.30e+01 | 2.90e-03 | 1.35e+01 | 9.97e-01 | Female-biased |
| BLCA | PABPC3 | exon_skip_143169 | 8.13e+00 | 1.07e-02 | 8.48e+00 | 9.83e-01 | Female-biased |
| BLCA | QKI | exon_skip_143169 | 1.35e+01 | 2.27e-03 | 1.40e+01 | 9.98e-01 | Female-biased |
| SARC | KHDRBS1 | exon_skip_143172 | 7.18e+00 | 9.54e-03 | 7.54e+00 | 9.80e-01 | Female-biased |
| SARC | MSI1 | exon_skip_143172 | 1.40e+01 | 1.23e-03 | 1.46e+01 | 9.99e-01 | Female-biased |
| SARC | QKI | exon_skip_143169 | 1.39e+01 | 9.99e-01 | 1.33e+01 | 1.15e-03 | Male-biased |
| SARC | QKI | exon_skip_143172 | 1.22e+01 | 3.13e-03 | 1.27e+01 | 9.96e-01 | Female-biased |
| PALB2 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs72781586 | chr16:17383236:A:G | - | 0.129835027859651 | 0.0046760802106489 | BLCA | Female-baised eQTL |
| rs8053503 | chr16:17357522:A:T | - | 0.125390378515351 | 0.00535920383318861 | BLCA | Female-baised eQTL |
| rs79389160 | chr16:27973639:G:A | - | 0.158212070673474 | 0.0263799948153461 | BLCA | Female-baised eQTL |
| rs72781536 | chr16:17350946:G:T | - | 0.113845751274054 | 0.0404879191499131 | BLCA | Female-baised eQTL |
| rs80094791 | chr16:17348902:C:T | - | 0.113044820993278 | 0.0446878514181078 | BLCA | Female-baised eQTL |
| rs3743955 | chr16:19121125:A:C | - | 0.0872735513778642 | 0.0152494536059704 | LUAD | Female-baised eQTL |
| rs3743956 | chr16:19121458:T:C | - | 0.0829448130126488 | 0.0181227212159548 | LUAD | Female-baised eQTL |
| rs12446979 | chr16:25627973:A:G | - | 0.0601831909378018 | 0.0192090504859456 | LUAD | Female-baised eQTL |
| rs2943312 | chr16:25629694:T:C | - | 0.0595393799076518 | 0.0213031822931526 | LUAD | Female-baised eQTL |
| rs2966239 | chr16:25629779:A:G | - | 0.0595393799076518 | 0.0213031822931526 | LUAD | Female-baised eQTL |
| rs2966238 | chr16:25629833:A:G | - | 0.0595393799076518 | 0.0213031822931526 | LUAD | Female-baised eQTL |
| rs2910846 | chr16:25629916:T:G | - | 0.0595393799076518 | 0.0213031822931526 | LUAD | Female-baised eQTL |
| rs2910847 | chr16:25631173:A:G | - | 0.0592987801714445 | 0.0233204158060873 | LUAD | Female-baised eQTL |
| rs2943310 | chr16:25631178:T:C | - | 0.0592987801714445 | 0.0233204158060873 | LUAD | Female-baised eQTL |
| rs2943309 | chr16:25631340:T:C | - | 0.0586319133295684 | 0.025669747000643 | LUAD | Female-baised eQTL |
| rs437545 | chr16:24200055:T:A | - | 0.0783073038803637 | 0.0263719880078158 | LUAD | Female-baised eQTL |
| rs11864339 | chr16:24982115:T:C | - | 0.0858584822136869 | 0.0342214478508701 | LUAD | Female-baised eQTL |
| rs8045116 | chr16:24983440:G:A | - | 0.0858584822136869 | 0.0342214478508701 | LUAD | Female-baised eQTL |
| rs1423639 | chr16:25634271:T:A | - | 0.0566227974534133 | 0.0357439743728735 | LUAD | Female-baised eQTL |
| rs1040354 | chr16:25634362:T:C | - | 0.0566227974534133 | 0.0357439743728735 | LUAD | Female-baised eQTL |
| rs12933885 | chr16:25634007:A:G | - | 0.0564287116691309 | 0.0373816154226149 | LUAD | Female-baised eQTL |
| rs12934442 | chr16:25634066:G:A | - | 0.0564287116691309 | 0.0373816154226149 | LUAD | Female-baised eQTL |
| rs1423638 | chr16:25634174:C:T | - | 0.0564287116691309 | 0.0373816154226149 | LUAD | Female-baised eQTL |
| rs1364011 | chr16:25631549:A:T | - | 0.0562148678400637 | 0.0405780997367226 | LUAD | Female-baised eQTL |
| rs16974979 | chr16:25633686:G:A | - | 0.0558049479900318 | 0.0413274919210707 | LUAD | Female-baised eQTL |
| rs35121326 | chr16:25372538:G:A | - | -0.0695832103825868 | 0.025263478388535 | COAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs1493867 | chr16:17820751:C:G | - | 0.0255287123209911 | 0.00709501001309173 | LUSC | Male-baised eQTL |
| rs1493866 | chr16:17820899:G:T | - | 0.0255287123209911 | 0.00709501001309173 | LUSC | Male-baised eQTL |
| rs8053373 | chr16:17824837:G:A | - | 0.0254747387922811 | 0.00782526162745085 | LUSC | Male-baised eQTL |
| rs12934279 | chr16:17829890:C:T | - | 0.0248169845824841 | 0.0114857441545072 | LUSC | Male-baised eQTL |
| rs6498744 | chr16:17823028:C:T | - | 0.0246941281178402 | 0.0127242408099551 | LUSC | Male-baised eQTL |
| rs8059715 | chr16:17825420:C:T | - | 0.0245896214841404 | 0.013617473561523 | LUSC | Male-baised eQTL |
| rs8046136 | chr16:17820605:T:C | - | 0.0244384935920724 | 0.0146848697935327 | LUSC | Male-baised eQTL |
| rs4257197 | chr16:17821528:A:G | - | 0.0244384935920724 | 0.0146848697935327 | LUSC | Male-baised eQTL |
| rs8050464 | chr16:17821995:G:A | - | 0.0244384935920724 | 0.0146848697935327 | LUSC | Male-baised eQTL |
| rs11646781 | chr16:17822258:T:C | - | 0.0243348273504367 | 0.0156592587150686 | LUSC | Male-baised eQTL |
| rs4474664 | chr16:17822334:T:C | - | 0.0229078388784326 | 0.0389512410866295 | LUSC | Male-baised eQTL |
| rs200676812 | chr16:24706979:T:A | - | 0.0916622643783504 | 0.0072389726433265 | COAD | Male-baised eQTL |
| rs9635492 | chr16:24706641:C:G | - | 0.0850650452324647 | 0.0140701186013714 | COAD | Male-baised eQTL |
| rs67546616 | chr16:24706930:G:A | - | 0.0850650452324647 | 0.0140701186013714 | COAD | Male-baised eQTL |
| rs7199130 | chr16:24707058:C:T | - | 0.0850650452324647 | 0.0140701186013714 | COAD | Male-baised eQTL |
| rs7199355 | chr16:24707216:A:G | - | 0.0850650452324647 | 0.0140701186013714 | COAD | Male-baised eQTL |
| rs60820369 | chr16:24707349:C:T | - | 0.0850650452324647 | 0.0140701186013714 | COAD | Male-baised eQTL |
| rs66587448 | chr16:24707444:A:G | - | 0.0850650452324647 | 0.0140701186013714 | COAD | Male-baised eQTL |
| rs67799000 | chr16:24707675:C:T | - | 0.0850650452324647 | 0.0140701186013714 | COAD | Male-baised eQTL |
| rs113271742 | chr16:24708294:G:A | - | 0.0850650452324647 | 0.0140701186013714 | COAD | Male-baised eQTL |
| rs75813157 | chr16:24708396:A:G | - | 0.0850650452324647 | 0.0140701186013714 | COAD | Male-baised eQTL |
| rs56666521 | chr16:24708476:G:C | - | 0.0850650452324647 | 0.0140701186013714 | COAD | Male-baised eQTL |
| rs7188815 | chr16:24708635:G:A | - | 0.0850650452324647 | 0.0140701186013714 | COAD | Male-baised eQTL |
| rs7188960 | chr16:24708666:G:A | - | 0.0850650452324647 | 0.0140701186013714 | COAD | Male-baised eQTL |
| rs7189584 | chr16:24709037:G:A | - | 0.0850650452324647 | 0.0140701186013714 | COAD | Male-baised eQTL |
| rs13380784 | chr16:24710183:C:T | - | 0.0850650452324647 | 0.0140701186013714 | COAD | Male-baised eQTL |
| rs56189906 | chr16:24710365:C:T | - | 0.0850650452324647 | 0.0140701186013714 | COAD | Male-baised eQTL |
| rs61366617 | chr16:24710807:G:A | - | 0.0850650452324647 | 0.0140701186013714 | COAD | Male-baised eQTL |
| rs7203925 | chr16:24711167:T:C | - | 0.0850650452324647 | 0.0140701186013714 | COAD | Male-baised eQTL |
| rs7190025 | chr16:24709443:C:G | - | 0.0835421672190397 | 0.0148498783720161 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| exon_skip_143165 | chr16:23607863:23608012 | Frame-shift | rs198188 | chr16:24124880:A:G | Distant upstream | 0.0194567047172885 | 0.0421729530247505 | LUAD | Female-baised sQTL |
| exon_skip_143165 | chr16:23607863:23608012 | Frame-shift | rs12920718 | chr16:23867367:C:T | Distant upstream | -0.0485312276300928 | 0.03343777365875 | PAAD | Female-baised sQTL |
| exon_skip_143165 | chr16:23607863:23608012 | Frame-shift | rs12931600 | chr16:23869770:C:T | Distant upstream | -0.0485312276300928 | 0.03343777365875 | PAAD | Female-baised sQTL |
| exon_skip_143165 | chr16:23607863:23608012 | Frame-shift | rs12929938 | chr16:23872801:T:A | Distant upstream | -0.0485312276300928 | 0.03343777365875 | PAAD | Female-baised sQTL |
| exon_skip_143165 | chr16:23607863:23608012 | Frame-shift | rs12934555 | chr16:23873965:G:A | Distant upstream | -0.0485312276300928 | 0.03343777365875 | PAAD | Female-baised sQTL |
| exon_skip_143165 | chr16:23607863:23608012 | Frame-shift | rs9940072 | chr16:23876862:G:T | Distant upstream | -0.0485312276300928 | 0.03343777365875 | PAAD | Female-baised sQTL |
| exon_skip_143165 | chr16:23607863:23608012 | Frame-shift | rs3785403 | chr16:23855702:G:C | Distant upstream | -0.0474115625435427 | 0.0413238760458076 | PAAD | Female-baised sQTL |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| exon_skip_143165 | chr16:23607863:23608012 | Frame-shift | rs208635 | chr16:22904006:A:G | Distant downstream | 0.0373320342299958 | 0.0437514637195552 | KIRC | Male-baised sQTL |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of PALB2 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000083093 | PALB2 | C0005586 | Bipolar Disorder | 1 | PSYGENET |
| ENSG00000083093 | PALB2 | C0006142 | Malignant neoplasm of breast | 1 | CTD_human |
| ENSG00000083093 | PALB2 | C0030297 | Pancreatic Neoplasm | 1 | CTD_human |
| ENSG00000083093 | PALB2 | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
| ENSG00000083093 | PALB2 | C0346647 | Malignant neoplasm of pancreas | 1 | CTD_human |
| ENSG00000083093 | PALB2 | C0376358 | Malignant neoplasm of prostate | 1 | CTD_human |
| ENSG00000083093 | PALB2 | C0678222 | Breast Carcinoma | 1 | CTD_human |
| ENSG00000083093 | PALB2 | C1257931 | Mammary Neoplasms, Human | 1 | CTD_human |
| ENSG00000083093 | PALB2 | C1458155 | Mammary Neoplasms | 1 | CTD_human |
| ENSG00000083093 | PALB2 | C1835817 | FANCONI ANEMIA, COMPLEMENTATION GROUP N | 1 | CTD_human |
| ENSG00000083093 | PALB2 | C4704874 | Mammary Carcinoma, Human | 1 | CTD_human |
